ProMIS Neurosciences Announces Third Quarter 2024 Financial …

1 day ago · Third Quarter 2024 Financial Highlights Cash and cash equivalents were $21.5 million as of September 30, 2024, compared to $12.6 million as of December 31, 2023. During the …

$21
OFF

ProMIS Neurosciences Announces Third Quarter 2024 Financial …

1 week from now

1 day ago · Third Quarter 2024 Financial Highlights Cash and cash equivalents were $21.5 million as of September 30, 2024, compared to $12.6 million as of December 31, 2023. During the …

promisneurosciences.com

$21
OFF

ProMIS Neurosciences Announces Third Quarter 2024 Financial …

1 week from now

1 day ago · Third Quarter 2024 Financial Highlights Cash and cash equivalents were $21.5 million as of September 30, 2024, compared to $12.6 million as of December 31, 2023.

businessinsider.com

$21
OFF

ProMIS Neurosciences Announces Third Quarter 2024 Financial …

1 week from now

1 day ago · The Q3 2024 results reveal significant financial developments for ProMIS Neurosciences. The company's cash position strengthened to $21.5 million , up from $12.6 …

stocktitan.net

$4
OFF

ProMIS Neurosciences Inc (PMN) Quarterly 10-Q Report

1 week from now

2 days ago · The filing includes financial statements for the quarter, showing an operating loss of $4.4 million and $10.8 million for the three and nine months ended September 30, 2024, …

qz.com

$9
OFF

ProMIS Neurosciences Announces Third Quarter 2024 Financial

1 week from now

1 day ago · Net income was $9.3 million for the quarter ended September 30, 2024, compared to a net loss of $2.4 million for the same period in 2023. The increase in net income was primarily …

nasdaq.com

$2417304
OFF

The Healthcare Foundation Of NJ Announces $2,417,304 In Third …

1 week from now

Sep 18, 2024 · The Healthcare Foundation of NJ (HFNJ) is pleased to announce that it has awarded $2,417,304 to eighteen nonprofit organizations in its third quarterly grant cycle of …

hfnj.org

FAQs about ProMIS Neurosciences Announces Third Quarter 2024 Financial … Coupon?

How did Promis Neurosciences perform in the third quarter?

“We made significant progress in the third quarter, highlighted by the positive results from our first-in-human Phase 1a clinical trial of PMN310 and the closing of a strong equity financing that could provide up to $122.7 million to advance our pipeline of neurodegenerative product candidates,” said Neil Warma, CEO of ProMIS Neurosciences. ...

Where is Promis Neurosciences located?

How much did Promis invest in public equity in 2024?

In July 2024, ProMIS completed a private investment in public equity (PIPE) financing that may provide up to $122.7 million in gross proceeds, which includes an initial upfront funding of $30.3 million and up to $92.4 million tied to exercise of warrants based on the Company achieving certain milestones. ...

Does Promis have a clinical trial of pmn310?

In October 2024, ProMIS presented positive data from all five cohorts in its first-in-human Phase 1a clinical trial of PMN310 in healthy volunteers at the 17 th Clinical Trials on Alzheimer’s Disease (CTAD) Conference, which took place from October 29 – November 1, 2024, in Madrid, Spain. ...

Where is Promis located?

ProMIS has offices in Cambridge, Massachusetts and Toronto, Ontario. Forward-Looking Statements Nasdaq has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. ...

What time is peg's third quarter 2024 earnings call?

NEWARK, N.J., Oct. 14, 2024 /PRNewswire/ -- Public Service Enterprise Group Incorporated (PSEG) will host its third quarter 2024 earnings call at 11:00 a.m. Public Service Enterprise Group Incorporated (PEG, Financial) has announced a significant development in its ongoing efforts to adjust its electric and gas distribution rates. ...